"Tumor Burden" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The total amount (cell number, weight, size or volume) of tumor cells or tissue in the body.
| Descriptor ID |
D047368
|
| MeSH Number(s) |
E05.041.124.892
|
| Concept/Terms |
Tumor Burden- Tumor Burden
- Burden, Tumor
- Tumor Load
- Load, Tumor
- Loads, Tumor
- Tumor Loads
Tumor Weight- Tumor Weight
- Tumor Weights
- Weight, Tumor
- Weights, Tumor
|
Below are MeSH descriptors whose meaning is more general than "Tumor Burden".
Below are MeSH descriptors whose meaning is more specific than "Tumor Burden".
This graph shows the total number of publications written about "Tumor Burden" by people in this website by year, and whether "Tumor Burden" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 1 | 2 |
| 2009 | 1 | 4 | 5 |
| 2010 | 2 | 7 | 9 |
| 2011 | 1 | 10 | 11 |
| 2012 | 1 | 12 | 13 |
| 2013 | 2 | 12 | 14 |
| 2014 | 0 | 15 | 15 |
| 2015 | 2 | 5 | 7 |
| 2016 | 0 | 16 | 16 |
| 2017 | 2 | 17 | 19 |
| 2018 | 0 | 9 | 9 |
| 2019 | 0 | 10 | 10 |
| 2020 | 1 | 11 | 12 |
| 2021 | 1 | 11 | 12 |
| 2022 | 0 | 1 | 1 |
| 2024 | 0 | 1 | 1 |
| 2025 | 0 | 3 | 3 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tumor Burden" by people in Profiles.
-
Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model. Sci Rep. 2026 May 16; 16(1).
-
Tumor burden-guided dosing contributes to mitigation of immunotoxicities following treatment with obecabtagene autoleucel in adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia. Haematologica. 2026 06 01; 111(6):1999-2010.
-
Measurable imaging-based changes in enhancement of intrahepatic cholangiocarcinoma after radiotherapy reflect physical mechanisms of response. NPJ Syst Biol Appl. 2025 Dec 12; 11(1):140.
-
Sequelae and Surgical Management of Giant Cardiac Myxoma. Tex Heart Inst J. 2025 Jan-Jun; 52(1):e248413.
-
Radiation Therapy Dose Escalation Failed to Improve Local Control for Intermediate-Risk Rhabdomyosarcoma on ARST1431: A Report From the Children's Oncology Group. Int J Radiat Oncol Biol Phys. 2025 09 01; 123(1):54-62.
-
Radiofrequency Ablation in Patients with Interstitial Lung Disease and Lung Neoplasm: A Retrospective Multicenter Study. J Vasc Interv Radiol. 2024 09; 35(9):1305-1312.
-
Systematic Evaluation of HLA-G 3'Untranslated Region Variants in Locally Advanced, Non-Metastatic Breast Cancer Patients: UTR-1, 2 or UTR-4 are Predictors for Therapy and Disease Outcome. Front Immunol. 2021; 12:817132.
-
BOLD asynchrony elucidates tumor burden in IDH-mutated gliomas. Neuro Oncol. 2022 01 05; 24(1):78-87.
-
Characteristics Associated with Tumor Development in Individuals Diagnosed with Beckwith-Wiedemann Spectrum: Novel Tumor-(epi)Genotype-Phenotype Associations in the BWSp Population. Genes (Basel). 2021 11 21; 12(11).
-
Loss of Hepatic Transcription Factor EB Attenuates Alcohol-Associated Liver Carcinogenesis. Am J Pathol. 2022 01; 192(1):87-103.